Efficacy and tolerability of a red-vine-leaf extract in patients suffering from chronic venous insufficiency - Results of a double-blind placebo-controlled study

European Journal of Vascular and Endovascular Surgery

Volumn 41, Issue 4, 2011, Pages 540-547

  Rabe, E ^a   Stucker M ^b   Esperester, A ^c   Schafer E ^c   Ottillinger, B ^d  

^a UNIVERSITY OF BONN   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^d Ottillinger Life Sciences ^*  (Germany)

Author keywords

Antistax ; AS195; Chronic venous insufficiency; Clinical study; Placebo controlled

Indexed keywords

ANTISTAX; AS 195; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BACKACHE; CEREBROVASCULAR ACCIDENT; CHRONIC VEIN INSUFFICIENCY; CONTROLLED STUDY; DERMATITIS; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FLATULENCE; HEART FAILURE; HUMAN; HYPERCHOLESTEROLEMIA; INTERVERTEBRAL DISK HERNIA; LEG PAIN; MAJOR CLINICAL STUDY; MALAISE; MULTICENTER STUDY; NASOPHARYNGEAL ASPIRATION; NONHUMAN; PERIPHERAL EDEMA; PLANT LEAF; PRIORITY JOURNAL; RADICULOPATHY; RANDOMIZED CONTROLLED TRIAL; RETINA DETACHMENT; RHEUMATIC POLYMYALGIA; SIDE EFFECT; SKIN ULCER; SLEEP DISORDER; SUPERINFECTION; THROMBOPHLEBITIS; TREATMENT RESPONSE; URTICARIA; VARICOSIS; VISUAL ANALOG SCALE; VOLUMETRY;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR AGENTS; CHRONIC DISEASE; DOUBLE-BLIND METHOD; EDEMA; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PLACEBO EFFECT; PLANT EXTRACTS; PLANT LEAVES; QUERCETIN; TABLETS; TIME FACTORS; TREATMENT OUTCOME; VENOUS INSUFFICIENCY; VITIS; YOUNG ADULT;

EID: 79953061581     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2010.12.003     Document Type: Article

References (18)

1. Van den Oever R, Hepp B, Debbaut B, Simon I. Socioeconomic impact of chronic venous insufficiency. An underestimated public health problem. Int Angiol 1998;17:161-7. (Pubitemid 28524059)
2. Fowkes FG, Evans CJ, Lee AJ. Prevalence and risk factors of chronic venous insufficiency. Angiology 2001;52(Suppl. 1):S5-15.
3. Rabe E, Pannier-Fischer F, Bromen K, Schuldt K, Stang A, Poncar Ch, et al. Bonner Venenstudie der Deutschen Gesellschaft für Phlebologie - Epidemiologische Untersuchung zur Frage der Häufigkeit und Ausprägung von chronischen Venenkrankheiten in der städtischen und ländlichen Wohnbevölkerung. Phlebologie 2003;32:1-14.
4. Bergan JJ, Schmid-Schönbein GW, Coleridge Smith PD, Nicolaides AN, Boisseau MR, Eklof B. Chronic venous disease. The New England Journal of Medicine 2006;355:488-98. (Pubitemid 44162276)
5. Frick RW. Three treatments for chronic venous insufficiency: escin, hydroxyethylrutoside, and daflon. Angiology 2000;51(3):197-205. (Pubitemid 30164933)
6. Pittler MH. Complementary therapies for chronic venous insufficiency. Focus on Alternative and Complementary Therapies 2001;6:3-5.
7. Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. The Cochrane Library; 2001. Issue 3.
8. Kalus U, Koscielny J, Grigorov A, Schaefer E, Peil H, Kiesewetter H. Clinical improvement of cutaneous microcirculation and oxygen supply in patients with chronic venous insufficiency by orally administered extract of red vine leaves AS195. A randomised, doubleblind, placebo-controlled cross-over study. Drugs in R&D 2004;5:63-71. (Pubitemid 38607627)
9. Kiesewetter H, Koscielny J, Kalus U, Vix JM, Peil H, Petrini O, et al. Efficacy of orally administered extract of red vine leaf AS195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II). A randomized, double-blind, placebo-controlled trial. Arzneimittelforschung 2000;50:109-17. (Pubitemid 30114838)
10. Martinez MJ, Bonfill X, Moreno RM, Vargas E, Capellà D. Phlebotonics for venous insufficiency. Cochrane Database Syst Rev 2005;3. CD003229.
11. Rabe E, Stücker M, Ottillinger B. Water displacement leg volumetry in clinical studies - a discussion of error sources. BMC Med Res Methodol 2010;10(1):5.
12. Marshall M, Loew D, Schwahn-Schreiber C. Hydroxyethylrutoside zur Behandlung der chronischen Veneninsuffizienz Grad I und II. Phlebologie 2005;34:157-64.
13. Marshall M. Medikamentöse Therapie von chronischen Venenleiden. TW Dermatologie 1993;23:244-8.
14. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Erlbaum; 1988.
15. Gallenkemper G, Bulling BJ, Gerlach H, Jünger M, Kahle B, Klüken N, et al. Leitlinien zur Diagnostik und Therapie der chronischen venösen Insuffizienz (CVI). Phlebologie 1998;27:32-5. (Pubitemid 28272012)
16. Deutsche Gesellschaft für Phlebologie. Diagnostik und Therapie des Ulcus cruris venosum. S3-Leitlinie der Deutschen Gesellschaft für Phlebologie. AWMF Guideline Register No. 037/009; August 2008.
17. Jünger M, Partsch B, Kahle B, Rabe E, Stenger D, Stücker M, et al. Leitlinie: Phlebologischer Kompressionsverband (PKV). AWMF Guideline Register No. 037/005; 25 Jun 2009.
18. Belcaro G, Cesarone MR, Ledda A, Cacchio M, Ruffini I, Ricci A, et al. 5-Year control and treatment of edema and increased capillary filtration in venous hypertension and diabetic micro-angiopathy using O-(beta-hydroxyethyl)- rutosides: a prospective comparative clinical registry. Angiology 2008;59(Suppl. 1): 14S-20S.